Measuring what matters: how do we show the benefits of cell therapy for...
By Meaghan Read – Community and Research Engagement Lead, Diabetes Victoria On 17th March 2025, I had the privilege of attending a workshop hosted by Breakthrough T1D in Amsterdam. The aim was to...
View ArticleCould a meeting in Germany make diabetes care better?
ACBRD takes part in a two-day meeting to develop new guidelines that could change how health professionals support people with diabetes. By Professor Jane Speight Living with diabetes isn’t just a...
View ArticleUnderstanding the personal impact of diabetes: PROMs and PREMs explained
What are they, why do they matter, and how do you choose them? By Professor Jane Speight and Dr Elizabeth Holmes-Truscott When new diabetes treatments, technologies, or behavioural interventions are...
View ArticleAre rural communities forgotten in diabetes research?
This ACBRD-led study explored ways to increase research participation for people with type 2 diabetes living in rural Australia By Dr Jo Jordan Driving two hours to see a GP. Waiting over 18 months to...
View ArticleRethinking hypo awareness in the era of diabetes technology
UK review highlights the importance of asking the right questions when assessing awareness of hypos, despite technological advances By Dr Uffe Søholm Low blood glucose (also called hypoglycaemia or...
View Article